References for Dr. Tom Roth’s interview

Written By Ana Rosenthal

  • Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults. Biol Psych 1996: 39 (6) 411-418.

  • Roth, T. Insomnia: definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine 2007. S Vol. 3, No. 5: S7-S10.

  • Johnson E, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. Journal of psychiatric research 2006: 40 (8), 700-708.

  • Roehrs T, Roth, T: Hyperarousal in insomnia and hypnotic dose escalation. Sleep Medicine. 2016: V 23: 16-20.

  • Vivek P, Roth T, Roehrs T, et al:, Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates. Sleep: 2017, Volume 40, Issue 2, 1 February 2017.

  • Drake CL, Kalmbach DA, Cheng P, Roth T, Tran KM, Cuamatzi-Castelan A, Atkinson R, SinghM, Tonnu CV, Fellman-Couture C. Can the orexin antagonist suvorexant preserve the ability to awaken to auditory stimuli while improving sleep? J Clin Sleep Med. 2019;15(9):1285–1291.

  • Roehrs T, Withrow D, Koshorek G, Verkler J, Bazan L, Roth T. Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo. J Clin Sleep Med. 2020;16(3):415–421.

Ana Rosenthal
Previous

References for Dr. Daniel Cardinali’s interview